Newsroom

In The Beat Newsletter

Sign up for the CANet monthly newsletter to stay informed with our Networks activities.

Media Inquiries

Fabian Folias
Director, Digital Marketing and Communications
media@canet-nce.ca
519-661-2111 x81353

  

“Given the number of patients suffering with atrial fibrillation and the significant healthcare costs associated with managing it, there is a critical need for innovative minimally invasive cardiac procedures that improve patient outcomes without increasing healthcare costs”

Dr. Jason Andrade
Cardiology Fellow, University of Calgary and CHAT Member

Recent News

Our Current Highlights

11
Jun

Discharging patients directly home from the emergency room – Guidelines to standardize acute atrial fibrillation and flutter (AAFF) treatment across Canada 

CANet has helped Dr. Ian Steill share an important fact with hospitals across Canada – the majority of AAFF patients can be effectively and safely treated in the emergency room and then discharged to return home. Steill, a CANet Investigator, clinical epidemiologist, and emergency medicine physician at The Ottawa Hospital Research Institute, received CANet’s Strategic...
Read More
11
Jun

‘CASMER’ Launched in Alberta – Reducing Canadian Healthcare Costs by Eliminating Syncope Hospitalizations

Calgary, AB, June 11, 2018 – Paramedics in Calgary and surrounding areas are now able to increase capacity in the Emergency Medical Services (EMS) system, thanks to the CANet-funded project, CASMER, Community Alternatives for Syncope Management in the Emergency Room. CANet investigator, CASMER project lead and professor at University of Calgary’s Faculty of Medicine Dr....
Read More
10
Jun

Job Posting – Project Manager, Planning & Development

Description The Cardiac Arrhythmia Network of Canada (CANet) is the gateway to arrhythmia research and development in Canada. One point of contact links pharmaceutical and biotechnology companies, government and not-a‐for‐profit organizations to world-leading Canadian arrhythmia researchers and resources. Our vision is to generate innovations in arrhythmia treatment and technologies that transform care, focus on the...
Read More
31
May

Identifying at-risk ventricular arrhythmia patients

As far back as 2005, Dr. Venkatesh Thiruganasambandamoorthy felt that the outcomes of adults with syncope seen in Canadian Emergency Departments (EDs) needed to be more fully investigated. So he led the study Outcomes in Canadian Emergency Department Syncope Patients – Are We Doing a Good Job? to see what could be learned. The study,...
Read More
09
May

Vasopressin Lowers Sepsis Afib Risk

Among patients in septic shock and other forms of distributive shock, the addition of the antidiuretic hormone vasopressin to standard anti-hypotensive treatment is associated with a lower risk for atrial fibrillation (AF), researchers report. In a meta-analysis that included 23 randomized clinical trials involving more than 3,000 patients in distributive shock, adding vasopressin to catecholamine...
Read More

Need More Info?

Have a story to share?


Yes, please subscribe me to the CANet newsletter